Effects of breathing booster training and inhalation of terbutaline and ambroxol aerosol on pulmonary function in postoperative lung cancer patients
10.3760/cma.j.issn.0254-1424.2011.09.017
- VernacularTitle:呼吸助力器训练联合雾化吸人治疗对肺癌患者术后肺功能的影响
- Author:
Chuanliang PENG
;
Rui NIU
;
Qifeng SUN
;
Bo CONG
;
Yunpeng ZHAO
;
Jiazhong GUO
;
Xiaogang ZHAO
- Publication Type:Journal Article
- Keywords:
Breathing;
Terbutaline;
Ambroxol;
Lung cancer
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2011;33(9):697-700
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effects of.breathing booster training and aerosol inhalation with terbutaline and ambroxol on pulmonary function in postoperative lung cancer patients. Methods A total of 84 patients requiring resection operations for lung cancer were randomly divided into treatment and control groups.In the peri-operative period,breathing booster training and terbutaline and ambroxol aerosol inhalation were given to the treatment group,while only aerosol inhalation was given to the control group.Therapeutic effects were evaluated according to patients pulmonary function and postoperative complications 2 weeks and 1 day before the operation,and again 2 weeks after the operation.Postoperative quality of life (QOL) was evaluated with St.George's respiratory questionnaire (SGRQ) 1 month after the operation. Results There was no statistically significant difference in average pulmonary function between the two groups 2 weeks before the operation.Two weeks after the operation,pulmonary function had decreased in both groups,but it was significantly better in the treatment group than in the control group.The treatment group also had significantly fewer pulmonary complications.The QOL of patients in the treatment group had improved significantly 1 month after the operation. Conclusion Breathing booster training and inhalation of terbutaline and ambroxol aerosol during the peri-operative period can significantly improve pulmonary function,reduce respiratory complications and improve the QOL of patients requiring lung cancer resection operations.This is most important for promoting their early recovery.